We have investigated the subcellular distribution of presenilin-1 (PS1) and presenilin-2 (PS2) in a variety of mammalian cell lines. In Iodixanol-based density gradients, PS1 derivatives show a biphasic distribution, cofractionating with membranes containing ER-resident proteins and an additional population of membranes with low buoyant density that do not contain markers of the Golgi complex, ERGIC, COP II vesicles, ER exit compartment, COP II receptor, Golgi SNARE, trans-Golgi network, caveolar membranes, or endocytic vesicles. Confocal immunofluorescence and immunoelectron microscopy studies fully supported the fractionation studies. These data suggest that PS1 fragments accumulate in a unique subcompartment(s) of the ER or ER to Golgi trafficking intermediates. Interestingly, the FAD-linked PS1 variants show a marked redistribution toward the heavier region of the gradient. Finally, and in contrast to PS1, PS2 fragments are detected preponderantly in more densely sedimenting membranes, suggesting that the subcellular compartments in which these molecules accumulate are distinct.
INTRODUCTION
Alzheimer's disease (AD), a progressive neurodegenerative disease, is characterized by the presence of neuritic plaques and neurofibrillary tangles in the brains of affected individual. Mutations in genes encoding APP, PS1, and PS2 are causative in the majority of pedigrees of early-onset FAD (Sherrington et al., 1995; Rogaev et al., 1995; Levy-Lahad et al., 1995; Alzheimer's Disease Collaborative Group, 1995) . With the exception of a PS1 mutation that destroys a splice acceptor site resulting in an in-frame deletion of amino acids 290-309 (⌬E9; Perez-Tur et al., 1995) , the mutations in PS1 and PS2 lead to amino acid substitutions. PS1 and PS2 are highly homologous proteins with eight putative transmembrane (TM) domains; the Nterminus, C-terminus, and a large hydrophilic loop between TMs 6 and 7 protrude into the cytoplasm (Doan et al., 1996; DeStrooper et al., 1997; Li and Greenwald, 1996, 1998) . Immunocytochemical studies have revealed that PS1 is present throughout the brain, with prominent immunoreactivity in neurons (Elder et al., 1996; Lee et al., 1996; Moussaour et al., 1996; Busciglio et al., 1997; Lah et al., 1997) .
In cultured cells and tissues, the preponderant PSrelated polypeptides that accumulate are N-terminal, ϳ30-35 kDa, and C-terminal, ϳ18-20 kDa derivatives (Thinakaran et al., 1996b; Kim et al., 1997; Podlisny et al., 1997) . The accumulation of PS1 derivatives is highly regulated and saturable (Thinakaran et al., 1996b; Lee et al., 1997) ; overexpression of human PS1 mRNA in brains of transgenic mice leads to modest (ϳ1.5-fold) elevations in the steady-state levels of PS1. Accumulation of human PS1 derivatives in transgenic mice is also accompanied by a compensatory and highly selective decrease in the steady-state levels of murine PS1 and PS2 derivatives (Thinakaran et al., 1997) . These observations, corroborated in stably trans-
